The Global Middle East and Asia Pacific Cell and Gene Therapy Market is estimated to be valued at US$ 4147.82 Th in 2024 and is expected to exhibit a CAGR of 7.5% over the forecast period 2024 to 2030
| Founded year: | Not set |
| Funding rounds: | Not set |
| Total funding amount: | Not set |